Article Information
PubMed
Print ISSN
Online ISSN
History
- Received May 21, 2020
- Accepted July 10, 2020
- Published online September 19, 2020.
Article Versions
- Earlier version (July 28, 2020 - 16:31).
- You are viewing the most recent version of this article.
Copyright & Usage
U.S. Government work not protected by U.S. copyright
Author Information
- Zeenat A. Shyr,
- Kirill Gorshkov,
- Catherine Z. Chen, and
- Wei Zheng
- National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland
- Address correspondence to:
Dr. Wei Zheng, National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, MSC: 3375, Bethesda, MD. E-mail: wzheng{at}mail.nih.gov
Statistics from Altmetric.com
Article usage
In this issue
SARS-CoV-2 Drug Discovery
Jump to section
- Article
- Abstract
- Introduction
- Overview of SARS-CoV-2 Genome and Protein Constituents
- Viral Entry Through the Binding of SARS-CoV-2 Spike Proteins to Angiotensin Converting Enzyme 2 Receptor
- SARS-CoV-2 Has Multiple Viral Entry Mechanisms
- Drug Development Strategies
- SARS-CoV-2 Viral Entry Inhibitors
- Viral Replication Inhibitors
- Host Cell and Viral Targets for Antiviral Drug Development
- Prophylactic Treatment of SARS-CoV-2 Infection
- Other Treatments in Clinical Trials for COVID-19
- Vaccines for SARS-CoV-2
- Perspectives and Conclusion
- Authorship Contributions
- Footnotes
- Abbreviations
- References
- Figures & Data
- Info & Metrics
- eLetters